Pallas Capital Advisors LLC purchased a new stake in shares of Builders FirstSource, Inc. (NYSE:BLDR – Free Report) during ...

The revenue forecasts for these drugs in diabetes and obesity combined stretch to >$150bn per annum (explaining why Lilly and Novo's stock prices ... by Akero, and 89bio (ETNB) make it to market ...

89bio (ETNB) announced that it has commenced an underwritten public offering of $100M of shares of its common stock or, in lieu of common stock to certain investors that so choose, pre-funded warrants ...

In addition, 89bio is expected to grant the underwriters of the offering an option for a period of 30 days to purchase up to an additional $15 million of shares of its common stock at the public ...

As of the latest data, 89bio Inc holds a market capitalization of approximately $869.517 million, with a current stock price of $8.21. The company's financial performance shows a GF Score of 40/ ...

However that may be, 89bio (NASDAQ:ETNB) was not a THR-β stock, so it fell on that news; and again, when resmetirom got its approval in March 2024, the stock fell, and has continued falling.

As of the latest data, 89bio Inc holds a market capitalization of approximately $869.517 million, with a current stock price of $8.21. The company's financial performance shows a GF Score of 40/100, ...

On October 17, 2024, Suvretta Capital Management, LLC executed a significant transaction involving the shares of 89bio Inc (NASDAQ ... the grant of non-qualified stock options to purchase an ...

raised its revenue forecast for the year and said the next five years would also be "healthy". The stock could go higher still, said Venson Tsai, an analyst at Cathay Futures Consultant in Taipei.

U.S.-listed shares of HSBC Holdings (HSBC) advanced Tuesday as the British financial firm's third-quarter results beat forecasts and it announced another $3 billion stock buyback. The bank ...

Making long-term predictions for individual stock prices is very difficult. Past performance doesn't guarantee future results. Whether a stock has done well or fared poorly, the tide can shift ...

On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 7,184 shares of 89bio Inc (NASDAQ:ETNB), a clinical-stage biopharmaceutical company. This ...